Binding of theophylline and its metabolites to human plasma proteins.
作者信息
Gundert-Remy U, Hildebrandt R
出版信息
Br J Clin Pharmacol. 1983 Nov;16(5):573-4. doi: 10.1111/j.1365-2125.1983.tb02220.x.
Abstract
摘要
相似文献
1
Binding of theophylline and its metabolites to human plasma proteins.
Br J Clin Pharmacol. 1983 Nov;16(5):573-4. doi: 10.1111/j.1365-2125.1983.tb02220.x.
2
Plasma protein binding of theophylline in dogs.
J Vet Pharmacol Ther. 1988 Mar;11(1):112-4. doi: 10.1111/j.1365-2885.1988.tb00128.x.
3
Clinical evaluation of theophylline binding to plasma protein in bronchial asthmatic patients.
J Clin Hosp Pharm. 1984 Sep;9(3):231-9. doi: 10.1111/j.1365-2710.1984.tb01081.x.
4
The binding of theophylline to serum proteins of hemodialysis patients.
J Dial. 1979;3(4):375-81. doi: 10.3109/08860227909063955.
5
The ex vivo plasma protein binding of theophylline in renal disease.
Br J Clin Pharmacol. 1985 Jun;19(6):823-5. doi: 10.1111/j.1365-2125.1985.tb02720.x.
6
Characterization of theophylline binding to serum proteins in pregnant and nonpregnant women.
Clin Pharmacol Ther. 1990 Jan;47(1):68-72. doi: 10.1038/clpt.1990.10.
7
Elimination kinetics and protein binding of theophylline in the rabbit.
Life Sci. 1981 Aug 3;29(5):473-6. doi: 10.1016/0024-3205(81)90213-7.
8
Theophylline disposition in patients with hepatic cirrhosis.
N Engl J Med. 1977 Jun 30;296(26):1495-7. doi: 10.1056/NEJM197706302962603.
9
Variability of the serum protein binding of theophylline in patients with asthma and cystic fibrosis.
Br J Clin Pharmacol. 1992 Jun;33(6):653-6. doi: 10.1111/j.1365-2125.1992.tb04096.x.
10
Theophylline binding to plasma proteins in patients with chronic obstructive pulmonary disease.
Int J Clin Pharmacol Res. 1986;6(5):397-401.
引用本文的文献
1
A "Single-Use" Ceramic-Based Electrochemical Sensor Chip Using Molecularly Imprinted Carbon Paste Electrode.
Sensors (Basel). 2020 Oct 16;20(20):5847. doi: 10.3390/s20205847.
2
Nonlinear renal excretion of theophylline and its metabolites, 1-methyluric acid and 1,3-dimethyluric acid, in rats.
Arch Pharm Res. 1994 Apr;17(2):124-30. doi: 10.1007/BF02974236.
3
Protein binding of theophylline.
Br J Clin Pharmacol. 1985 Apr;19(4):529-31. doi: 10.1111/j.1365-2125.1985.tb02684.x.
4
Absence of a clinically significant interaction between theophylline and furosemide.
Eur J Clin Pharmacol. 1987;33(5):487-91. doi: 10.1007/BF00544241.
5
Pharmacokinetics of theophylline and its metabolites in a patient undergoing continuous ambulatory peritoneal dialysis.
Clin Pharmacokinet. 1988 Dec;15(6):390-5. doi: 10.2165/00003088-198815060-00003.
6
Variability of the serum protein binding of theophylline in patients with asthma and cystic fibrosis.
Br J Clin Pharmacol. 1992 Jun;33(6):653-6. doi: 10.1111/j.1365-2125.1992.tb04096.x.
本文引用的文献
1
Interactions of xanthine molecules with bovine serum albumin.
J Pharm Sci. 1962 Jan;51:66-71. doi: 10.1002/jps.2600510112.
2
Factors influencing theophylline serum protein binding.
Clin Pharmacol Ther. 1982 Oct;32(4):490-6. doi: 10.1038/clpt.1982.193.
3
Competitive action of contrast media on the uric acid-albumin binding.
J Pharmacol Methods. 1982 Jan;7(1):1-6. doi: 10.1016/0160-5402(82)90052-3.
4
Nonlinear theophylline elimination.
Clin Pharmacol Ther. 1982 Mar;31(3):358-69. doi: 10.1038/clpt.1982.46.
5
Non-linear elimination processes of theophylline.
Eur J Clin Pharmacol. 1983;24(1):71-8. doi: 10.1007/BF00613930.
6
The binding of urate to plasma proteins determined by means of equilibrium dialysis.
J Lab Clin Med. 1970 Mar;75(3):503-10.
7
Plasma concentrations of the urate-binding alpha 1-2 -globulin in patients with different types of primary gout as compared to healthy control subjects.
Eur J Clin Invest. 1972 Jan;2(2):66-71. doi: 10.1111/j.1365-2362.1972.tb00571.x.
8
Effect of pH on the binding of theophylline to serum proteins.
Am Rev Respir Dis. 1979 Jul;120(1):83-6. doi: 10.1164/arrd.1979.120.1.83.
Zotero 插件